Cargando…
A more physiological approach to lipid metabolism alterations in cancer: CRC-like organoids assessment
Precision medicine might be the response to the recent questioning of the use of metformin as an anticancer drug in colorectal cancer (CRC). Thus, in order to establish properly its benefits, metformin application needs to be assayed on the different progression stages of CRC. In this way, intestina...
Autores principales: | Cruz-Gil, Silvia, Sánchez-Martínez, Ruth, Wagner-Reguero, Sonia, Stange, Daniel, Schölch, Sebastian, Pape, Kristin, Ramírez de Molina, Ana |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Public Library of Science
2019
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6655698/ https://www.ncbi.nlm.nih.gov/pubmed/31339921 http://dx.doi.org/10.1371/journal.pone.0219944 |
Ejemplares similares
-
Correction: A more physiological approach to lipid metabolism alterations in cancer: CRC-like organoids assessment
por: Cruz-Gil, Silvia, et al.
Publicado: (2019) -
Human gastric cancer modelling using organoids
por: Seidlitz, Therese, et al.
Publicado: (2019) -
Lipid Metabolism Interplay in CRC—An Update
por: Krauß, Dana, et al.
Publicado: (2022) -
Re-expression of REG family and DUOXs genes in CRC organoids by co-culturing with CAFs
por: Naruse, Mie, et al.
Publicado: (2021) -
Integrated multi-omics analyses on patient-derived CRC organoids highlight altered molecular pathways in colorectal cancer progression involving PTEN
por: Codrich, Marta, et al.
Publicado: (2021)